DOI:
10.1055/s-00000146
Diabetes aktuell
LinksClose Window
References
Blonde L. et al.
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.
Diabetes Obes Metab 2006; 8 (4): 436-447
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.